• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

India’s polio vaccination provides valuable insights for mass vaccination campaigns

Bioengineer by Bioengineer
May 6, 2021
in Immunology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Reach Alliance.

Lessons Learned from India’s Polio Vaccination Program Provide Valuable Insights for Future Mass Vaccination Initiatives.

Toronto – As India urgently scales up its vaccination campaign for the COVID-19 virus, a new study which examined the country’s successful program to eliminate polio provides guidance on how this and future mass immunization campaigns can be successful, especially in vaccinating hard to reach groups.

The study, conducted by students and faculty with the Reach Alliance, a research initiative based at the University of Toronto’s Munk School of Global Affairs & Public Policy, says that medicine alone is insufficient for the elimination of disease.

The World Health Organization declared India polio-free in 2014. While the country had the medical ability to eliminate polio for decades, new managerial strategies were necessary to achieve polio elimination among India’s hardest to reach, including within religious minorities and impoverished communities.

“We found that the barriers to vaccination were deeply rooted in larger issues of social trust and political vulnerability,” says, Anita M. McGahan, University Professor and the George E. Connell Chair in Organizations & Society at the University’s Rotman School of Management and Munk School. “Many of these same issues will need to be dealt with by governments and health agencies globally in order to vaccinate the most vulnerable today against COVID-19.”

The study found that managerial strategies were necessary to achieve polio elimination among India’s hardest to reach. Namely, these strategies were the bundling of basic healthcare services when marketing the vaccine, which tackled existing essential healthcare concerns in the communities; engaging stakeholders in vulnerable communities including religious leaders, local media outlets, employers of migrant workers, and private health providers; and, implementing accountability mechanisms among healthcare workers which improved the accuracy of both polio surveillance and vaccination data.

###

In addition to Prof. McGahan, the study was jointly authored by Alejandra Bellatin, UofT BA’19, Azana Hyder, MGA’21, Sampreeth Rao, a UofT medical student, and Peter Zhang, a student in the DPharm/MBA program at the Leslie Dan Faculty of Pharmacy and Rotman School.

The study was published by BMJ Global Health and is available at https://gh.bmj.com/content/6/4/e005125.

The Reach Alliance is a student-led, faculty-driven, multi-disciplinary research initiative dedicated to investigating the pathways to success for innovative development programs that are reaching the world’s most marginalized populations. Housed at the University of Toronto’s Munk School of Global Affairs & Public Policy, the Reach Alliance is supported by the Mastercard Center for Inclusive Growth.

Bringing together high-impact faculty research and thought leadership on one searchable platform, the new Rotman Insights Hub offers articles, podcasts, opinions, books and videos representing the latest in management thinking and providing insights into the key issues facing business and society. Visit http://www.rotman.utoronto.ca/insightshub.

The Rotman School of Management is part of the University of Toronto, a global centre of research and teaching excellence at the heart of Canada’s commercial capital. Rotman is a catalyst for transformative learning, insights and public engagement, bringing together diverse views and initiatives around a defining purpose: to create value for business and society. For more information, visit http://www.rotman.utoronto.ca

For more information:

Ken McGuffin

Manager, Media Relations

Rotman School of Management

University of Toronto

E-mail: [email protected]

Media Contact
Ken McGuffin
[email protected]

Original Source

https://www.rotman.utoronto.ca/Connect/MediaCentre/NewsReleases/20210506

Related Journal Article

http://dx.doi.org/10.1136/bmjgh-2021-005125

Tags: Developing CountriesDisease in the Developing WorldInfectious/Emerging DiseasesMedicine/HealthPolicy/EthicsPublic HealthSocioeconomicsVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1165 shares
    Share 465 Tweet 291
  • New Study Reveals the Science Behind Exercise and Weight Loss

    101 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

mTOR Dysregulation Drives Lung Repair Failure in LAM

Inflammation Biomarkers Signal High Lung Tumor Mutations

September 2025 Spotlight: Breakthrough Discoveries from City of Hope Research

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.